Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda

Breakthrough personalized mRNA vaccine cuts melanoma recurrence risk by 50% when combined with Keytruda, Moderna CEO reveals ...
BioSpace

BioNTech’s Multi-Modality Play Outpaces Moderna’s mRNA-Focused Pipeline

After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.
PharmExec

ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report

According to public statements and social media posts from X, ACIP vice chair Robert Malone (a public ally of HHS secretary Robert F. Kennedy Jr.) publicly accused FDA Commissioner Marty Makary of ...
Fox Business

FDA delays Moderna for adolescents to review rare side effect

The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -1.69% COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of a rare ...
ABC7

FDA adds warning to COVID vaccines about risk of heart inflammation

ATLANTA -- The US Food and Drug Administration added a warning about the risk of myocarditis and pericarditis to fact sheets for Moderna and Pfizer-BioNTech COVID-19 vaccines Friday. The warning notes ...